Short answer
IRONWOOD PHARMACEUTICALS INC (IRWD) filed an 8-K current report with the SEC on June 18, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 5.07 (Submission of Matters to a Vote of Security Holders). Ironwood held its 2026 Annual Meeting on June 16, 2026.
IRONWOOD PHARMACEUTICALS INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Ironwood held its 2026 Annual Meeting on June 16, 2026
- Section excerpt ends before disclosing director elections, officer departures, or compensation changes
Item 5.07 · Submission of Matters to a Vote of Security Holders
- All eight director nominees elected to one-year terms through the 2027 Annual Meeting
- Alexander Denner received the lowest support, with 104,323,731 votes for and 5,313,973 withheld
- Executive compensation approved on an advisory basis, with 104,461,936 votes for
- Plan Amendment approved, with 104,066,785 votes for
- KPMG LLP ratified as 2026 independent auditor, with 121,957,895 votes for
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other IRONWOOD PHARMACEUTICALS INC 8-K filings
Get the next IRWD 8-K as it lands
Follow IRWD for push alerts, or ask the research agent what this filing means.